과제정보
This work was supported by the National Research Foundation of Korea (NRF) funded by the Korea government (MSIT) (NRF-2020R1C1C1007553, 2023R1A2C1005313 to Sung-Eun Kim, NRF-2022R1F1A1074668 to Min Jung Kim).
참고문헌
- Frontera WR, Ochala J. Skeletal muscle: a brief review of structure and function. Calcif Tissue Int 2015; 96(3): 183-195. https://doi.org/10.1007/s00223-014-9915-y
- Schmidt M, Schuler SC, Huttner SS, von Eyss B, von Maltzahn J. Adult stem cells at work: regenerating skeletal muscle. Cell Mol Life Sci 2019; 76(13): 2559-2570. https://doi.org/10.1007/s00018-019-03093-6
- Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab 2014; 307(6): E469-E484. https://doi.org/10.1152/ajpendo.00204.2014
- Chen TH, Koh KY, Lin KM, Chou CK. Mitochondrial dysfunction as an underlying cause of skeletal muscle disorders. Int J Mol Sci 2022; 23(21): 12926.
- Wagatsuma A, Sakuma K. Mitochondria as a potential regulator of myogenesis. Sci World J 2013; 2013: 593267.
- Short KR, Bigelow ML, Kahl J, Singh R, Coenen-Schimke J, Raghavakaimal S, et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A 2005; 102(15): 5618-5623. https://doi.org/10.1073/pnas.0501559102
- Sreekumar R, Nair KS. Skeletal muscle mitochondrial dysfunction & diabetes. Indian J Med Res 2007; 125(3): 399-410.
- Sardao VA, Pereira SL, Oliveira PJ. Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injury. Expert Opin Drug Saf 2008; 7(2): 129-146. https://doi.org/10.1517/14740338.7.2.129
- Barreto R, Waning DL, Gao H, Liu Y, Zimmers TA, Bonetto A. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs. Oncotarget 2016; 7(28): 43442-43460. https://doi.org/10.18632/oncotarget.9779
- Pedrosa MB, Barbosa S, Vitorino R, Ferreira R, Moreira-Goncalves D, Santos LL. Chemotherapy-induced molecular changes in skeletal muscle. Biomedicines 2023; 11(3): 905.
- Yadav A, Yadav SS, Singh S, Dabur R. Natural products: potential therapeutic agents to prevent skeletal muscle atrophy. Eur J Pharmacol 2022; 925: 174995.
- Jeong SH, Kim BB, Lee JE, Ko Y, Park JB. Evaluation of the effects of Angelicae dahuricae radix on the morphology and viability of mesenchymal stem cells. Mol Med Rep 2015; 12(1): 1556-1560. https://doi.org/10.3892/mmr.2015.3456
- Okada R, Abe H, Okuyama T, Nishidono Y, Ishii T, Sato T, et al. Comparison of the anti-inflammatory activities of furanocoumarins from the roots of Angelica dahurica. Bioact Compd Health Dis 2021; 4(12): 287-300. https://doi.org/10.31989/bchd.v4i12.866
- Liu Y, Peng TS, Hu XD, Li SJ, He YH, Hu F, et al. Oxypeucedanin hydrate monoacetate isolated from Angelica dahurica induces apoptosis in Caco-2 colon carcinoma cells through the mediation of PI3K-signalling pathway and inhibition of cancer cell migration. Bangladesh J Pharmacol 2016; 11(2): 402.
- Wu Y, Wu Y, Yu J, Zhang Y, Li Y, Fu R, et al. Irisin ameliorates D-galactose-induced skeletal muscle fibrosis via the PI3K/Akt pathway. Eur J Pharmacol 2023; 939: 175476.
- Seo WD, Kim JY, Ryu HW, Kim JH, Han SI, Ra JE, et al. Identification and characterisation of coumarins from the roots of Angelica dahurica and their inhibitory effects against cholinesterase. J Funct Foods 2013; 5(3): 1421-1431. https://doi.org/10.1016/j.jff.2013.05.011
- Baek NI, Ahn EM, Kim HY, Park YD. Furanocoumarins from the root of Angelica dahurica. Arch Pharm Res 2000; 23(5): 467-470. https://doi.org/10.1007/BF02976574
- Le Grand F, Rudnicki MA. Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Biol 2007; 19(6): 628-633. https://doi.org/10.1016/j.ceb.2007.09.012
- Rahman FA, Quadrilatero J. Mitochondrial network remodeling: an important feature of myogenesis and skeletal muscle regeneration. Cell Mol Life Sci 2021; 78(10): 4653-4675. https://doi.org/10.1007/s00018-021-03807-9
- Barreto R, Mandili G, Witzmann FA, Novelli F, Zimmers TA, Bonetto A. Cancer and chemotherapy contribute to muscle loss by activating common signaling pathways. Front Physiol 2016; 7: 472.
- Parsons MJ, Campos I, Hirst EM, Stemple DL. Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. Development 2002; 129(14): 3505-3512. https://doi.org/10.1242/dev.129.14.3505